Advanced Search

 

Study ID Status Title Patient Level Data
29060/299 Completed A Double-Blind Study Comparing The Efficacy and Tolerability of Paroxetine and Amitriptyline In Patients With Severe Depression.
29060/303 Completed A double blind, placebo controlled study to determine the effects of subchronic paroxetine treatment on nocturnal hormonal secretion and sleep in healthy male volunteers
29060/308 Completed Early clinical evaluation of a new antidepressant: A double-blind parallel study comparing paroxetine 30mg daily with amitriptyline 150mg daily
29060/309 Completed Early Clinical Evaluation of a New Antidepressant: A Double-Blind Parallel Study Comparing Paroxetine 30mg Daily with Amitriptyline 100mg Daily
29060/310 Completed Early Clinical Evaluation of a New Antidepressant: Double-Blind Parallel Study Comparing Paroxetine 30mg Daily with Amitriptyline 150mg Daily
29060/311 Completed Early clinical evaluation of a new antidepressant: An open pilot study of paroxetine 40mg daily
29060/312 Completed A Phase II Pharmacokinetic Double Blind Study Comparing Paroxetine with Amitriptyline in Depressed Patients
29060/313 Completed A study to assess the efficacy and pharmacokinetics of paroxetine in depressed geriatric patients
29060/314 Completed Double Blind Parallel Study Comparing Paroxetine, 30mg Daily, and Amitriptyline, 150mg Daily, in Depressed Patients
29060/315 Completed Early clinical evaluation of a new antidepressant: An open pilot study of paroxetine 40mg daily
29060/316 Completed Early Clinical Evaluation of a New Antidepressant: A Double-Blind Parallel Study Comparing Paroxetine 30mg Daily with Amitriptyline 150mg Daily
29060/317 Completed An early clinical evaluation of a new antidepressant: An open study of paroxetine 40mg o.d.
29060/318 Completed Early Clinical Evaluation of a New Antidepressant: A Double-Blind Parallel Study Comparing Paroxetine 30mg Daily with Amitriptyline 150mg Daily
29060/319 Completed Early clinical evaluation of a new antidepressant: A double-blind parallel study comparing paroxetine 30mg daily, with amitriptyline 150mg daily.
29060/320 Completed An open labelled study to investigate the safety and tolerability of paroxetine when single oral dosing of 40 mg of paroxetine in healthy volunteers
29060/322 Completed Phase I clinical investigation of paroxetine. The pharmacokinetics, safety and tolerance of single and repeat oral administration of paroxetine in healthy volunteers
29060/326 Completed A double-blind, randomised multi centre study to assess the safety and tolerability of paroxetine and amitriptyline in depressed subjects stabilised on lithium treatment
29060/327 Completed A double-blind, placebo-controlled, parallel group study of paroxetine in the treatment of dysthymia. Study Listed on ClinicalStudyDataRequest.com
29060/329 Completed A Multi-center, Double-blind, Placebo-Controlled Study of Paroxetine and Imipramine in Adolescents with Unipolar Major Depression - Acute Phase Study Listed on ClinicalStudyDataRequest.com
29060/329_1 Completed A Multi-center, Double-blind, Placebo-Controlled Study of Paroxetine and Imipramine in Adolescents with Unipolar Major Depression - Continuation Phase. Study Listed on ClinicalStudyDataRequest.com
29060/331 Completed Paroxetine in Depressed Patients with Ischemic Heart Disease- A Randomized Safety Study
29060/332 Completed A Double-Blind, Multicentre Study to Assess the Efficacy and Tolerability of Paroxetine and Amitriptyline in Patients With a Mild, Moderate, or Severe Depressive Episode Associated With Rheumatoid Arthritis
29060/348 Completed Bioequivalence study of paroxetine hydrochloride formulations: bioequivalence study between two paroxetine hydrochloride formulations (10 mg tablet and 20 mg tablet) in healthy adult volunteers
29060/352 Completed A Double-Blind, Placebo-Controlled, Comparison of Imipramine and Paroxetine in the Treatment of Bipolar Depression
29060/353 Completed A Ten-Week, Single-Blind, Multicentre Study Evaluating the Efficacy and Tolerability of Paroxetine vs. Desipramine in the Treatment of Outpatients with Major Depression According to DSM-III-R

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.